Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of XYD-9668-198 in advanced solid tumors
CTR20231203Phase 2Active
- Sponsor
- NewYunda
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of XYD-9668-198 in Nonhematologic neoplasms, sponsored by NewYunda. Started May 2023; status: active.
02
Drugs
XYD-9668-198
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on CTR20231203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231203.